LGM Pharma
Jesse Gremminger, MBA, has a diverse and extensive work experience. Jesse currently serves as the Director of Operations at LGM Pharma since 2020. Prior to this, Jesse held the position of Director of Operations at Nexgen Pharma from 2014 to 2020, where they were responsible for overseeing various departments and ensuring compliance with cGMP standards. Before Nexgen, they worked at Elge, Inc from 2010 to 2014, first as a Business Development Officer and then as the Director of Operations. At Elge, Jesse played a key role in growing their monthly revenue from $150K to $400K. Overall, Jesse's experience showcases their expertise in strategic planning, operations management, and business development.
Jesse Gremminger, MBA, has a strong education background in business and leadership. Jesse completed their Executive MBA from the University of Houston, C.T. Bauer College of Business from 2016 to 2018, with a focus on Organizational Leadership. Prior to that, Jesse obtained their Bachelor of Business Administration degree in Business Administration and Management from Texas Lutheran University between 2005 and 2008.
In addition to their formal education, Jesse has also acquired some valuable certifications. Jesse obtained the OSHA 10-Hour Gen. Industry certification from Trainer Jack Stassi in December 2020. Furthermore, in May 2020, they completed the Train the Trainer Forklift Operator Class I-V certification from Eversafe Media Inc.
Jesse's educational and certification achievements demonstrate their dedication to enhancing their business knowledge and leadership skills.
This person is not in any offices
LGM Pharma
LGM Pharma is a leading CDMO provider of comprehensive API sourcing and drug product contract development and manufacturing solutions to the pharmaceutical industry. We secure and optimize your supply chain with our extensive qualified API partner network, global drug product development and manufacturing facilities, and regulatory and market intelligence services delivering customized solutions that get your products to market faster. Full-service, expert support that accelerates the new product pathway. Now that’s smart. • Established in 2005 • ISO 9001-2015 QMS certified company • CGMP systems in accordance with ICH Q7 • Main business segments: R&D / Biotech / CDMO / Specialty Pharma Companies, New Drug Delivery Technologies (NDA/505b2) – with heavy concentration on injectables, transdermal, nasal, inhalation, ophthalmic & sublingual drug deliveries Our products originate from our API manufacturing partner sites who are approved by the leading regulatory authorities, such as the US-FDA, EDQM, TGA, UK-MHRA, PMDA etc. LGM’s industry experience enables us to support our clients throughout the entire pathway of drug development, from discovery through commercial production. Based on the scale and scope of development projects with which we are involved, we are able to provide our customers with a seasoned perspective and valuable market insight. LGM Pharma has enhanced its position as a leading supplier of newly approved APIs, including full technical documentation and regulatory support. Our Clients: At LGM Pharma, our clients’ needs are our top priority, and we support our client base consisting of a diverse array of pharma companies, including: • Contract Research, Development & Manufacturing Organizations • Specialty Pharma and Novel Drug Delivery Systems • R&D & Biotech Companies • Generic Pharma Companies • Chemical Catalog Companies • OTC & Private Label Manufacturers • Academic & Government Laboratories • Pharmacy Compounding Industry